WBG
Wharton Business Group’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.16M | Buy |
53,115
+4,910
| +10% | +$199K | 0.09% | 66 |
|
|
2025
Q1 | $2.11M | Buy |
48,205
+4,360
| +10% | +$191K | 0.1% | 66 |
|
|
2024
Q4 | $1.89M | Hold |
43,845
| – | – | 0.09% | 67 |
|
|
2024
Q3 | $1.95M | Hold |
43,845
| – | – | 0.09% | 69 |
|
|
2024
Q2 | $1.74M | Hold |
43,845
| – | – | 0.09% | 70 |
|
|
2024
Q1 | $1.89M | Hold |
43,845
| – | – | 0.09% | 65 |
|
|
2023
Q4 | $1.83M | Buy |
43,845
+770
| +2% | +$32.1K | 0.09% | 68 |
|
|
2023
Q3 | $1.71M | Hold |
43,075
| – | – | 0.1% | 67 |
|
|
2023
Q2 | $1.77M | Hold |
43,075
| – | – | 0.12% | 61 |
|
|
2023
Q1 | $1.77M | Hold |
43,075
| – | – | 0.11% | 66 |
|
|
2022
Q4 | $1.76M | Sell |
43,075
-7,135
| -14% | -$292K | 0.1% | 68 |
|
|
2022
Q3 | $2.02M | Hold |
50,210
| – | – | 0.14% | 60 |
|
|
2022
Q2 | $2.11M | Hold |
50,210
| – | – | 0.14% | 58 |
|
|
2022
Q1 | $2.27M | Buy |
50,210
+6,790
| +16% | +$307K | 0.14% | 54 |
|
|
2021
Q4 | $2M | Buy |
43,420
+625
| +1% | +$28.8K | 0.12% | 55 |
|
|
2021
Q3 | $2.03M | Sell |
42,795
-33,300
| -44% | -$1.58M | 0.21% | 31 |
|
|
2021
Q2 | $3.94M | Sell |
76,095
-8,230
| -10% | -$426K | 0.31% | 42 |
|
|
2021
Q1 | $4.25M | Hold |
84,325
| – | – | 0.33% | 43 |
|
|
2020
Q4 | $4.39M | Sell |
84,325
-28,350
| -25% | -$1.48M | 0.36% | 40 |
|
|
2020
Q3 | $4.9M | Sell |
112,675
-8,155
| -7% | -$355K | 0.45% | 38 |
|
|
2020
Q2 | $5.19M | Sell |
120,830
-6,451
| -5% | -$277K | 0.5% | 38 |
|
|
2020
Q1 | $4.59M | Sell |
127,281
-4,390
| -3% | -$158K | 0.52% | 36 |
|
|
2019
Q4 | $6.01M | Buy |
131,671
+29,200
| +28% | +$1.33M | 0.56% | 35 |
|
|
2019
Q3 | $3.65M | Sell |
102,471
-2,409
| -2% | -$85.7K | 0.37% | 41 |
|
|
2019
Q2 | $4.18M | Hold |
104,880
| – | – | 0.43% | 36 |
|
|
2019
Q1 | $4.36M | Buy |
104,880
+3,655
| +4% | +$152K | 0.45% | 37 |
|
|
2018
Q4 | $3.71M | Sell |
101,225
-5,115
| -5% | -$187K | 0.44% | 38 |
|
|
2018
Q3 | $5.16M | Sell |
106,340
-625
| -0.6% | -$30.4K | 0.51% | 33 |
|
|
2018
Q2 | $4.6M | Buy |
106,965
+120
| +0.1% | +$5.16K | 0.48% | 35 |
|
|
2018
Q1 | $4.47M | Buy |
106,845
+5,685
| +6% | +$238K | 0.46% | 35 |
|
|
2017
Q4 | $4.4M | Sell |
101,160
-120,605
| -54% | -$5.25M | 0.46% | 36 |
|
|
2017
Q3 | $9.44M | Buy |
221,765
+605
| +0.3% | +$25.7K | 1% | 25 |
|
|
2017
Q2 | $9.52M | Sell |
221,160
-6,035
| -3% | -$260K | 1.01% | 26 |
|
|
2017
Q1 | $9.5M | Sell |
227,195
-8,810
| -4% | -$369K | 1.02% | 29 |
|
|
2016
Q4 | $9.23M | Buy |
236,005
+42,905
| +22% | +$1.68M | 1.09% | 28 |
|
|
2016
Q3 | $8.53M | Sell |
193,100
-72,595
| -27% | -$3.21M | 1.05% | 32 |
|
|
2016
Q2 | $11.1M | Buy |
265,695
+5,155
| +2% | +$215K | 1.31% | 28 |
|
|
2016
Q1 | $10.5M | Buy |
260,540
+16,515
| +7% | +$665K | 1.16% | 31 |
|
|
2015
Q4 | $12.5M | Buy |
244,025
+3,885
| +2% | +$199K | 1.24% | 28 |
|
|
2015
Q3 | $11.3M | Buy |
240,140
+120,375
| +101% | +$5.65M | 1.11% | 33 |
|
|
2015
Q2 | $14.9K | Sell |
119,765
-1,025
| -0.8% | -$128 | 0.99% | 28 |
|
|
2015
Q1 | $14.9M | Sell |
120,790
-2,455
| -2% | -$303K | 1.23% | 31 |
|
|
2014
Q4 | $13.3M | Buy |
123,245
+3,595
| +3% | +$388K | 1.1% | 30 |
|
|
2014
Q3 | $12.7M | Buy |
119,650
+685
| +0.6% | +$72.6K | 1.13% | 31 |
|
|
2014
Q2 | $12.3M | Buy |
118,965
+46,715
| +65% | +$4.85M | 1.36% | 25 |
|
|
2014
Q1 | $6.76M | Sell |
72,250
-3,210
| -4% | -$300K | 0.55% | 51 |
|
|
2013
Q4 | $6.64M | Buy |
75,460
+5,050
| +7% | +$444K | 0.56% | 47 |
|
|
2013
Q3 | $5.42M | Sell |
70,410
-1,750
| -2% | -$135K | 0.46% | 56 |
|
|
2013
Q2 | $5.09M | Buy |
+72,160
| New | +$5.09M | 0.44% | 56 |
|